deltatrials
Unknown PHASE4 NCT01745081

Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial Craniotomies

Comparison of the Efficacy Between 20% Mannitol and 3% Hypertonic Saline, Given as a Bolus at the Beginning of Elective Supratentorial Craniotomy for Tumor Resection, in Favoring Cerebral Relaxation Evaluated by a Sub-dural Intracranial Pressure Measurement.

Sponsor: Université de Sherbrooke

Conditions Intracranial Pressure Osmotherapy
Interventions 20% mannitol bolus administration Hypertonic saline 3% bolus administration
Updated 5 times since 2017 Last updated: Dec 6, 2012 Started: Sep 30, 2012 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

Listed as NCT01745081, this PHASE4 trial focuses on Intracranial Pressure and Osmotherapy and remains ongoing. Sponsored by Université de Sherbrooke, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Université de Sherbrooke
Data source: Université de Sherbrooke

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Sherbrooke, Canada